ALGS
Price
$9.79
Change
+$0.43 (+4.59%)
Updated
Sep 26 closing price
Capitalization
68.05M
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
825.75K
38 days until earnings call
Interact to see
Advertisement

ALGS vs SQZB

Header iconALGS vs SQZB Comparison
Open Charts ALGS vs SQZBBanner chart's image
Aligos Therapeutics
Price$9.79
Change+$0.43 (+4.59%)
Volume$55.89K
Capitalization68.05M
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$316
Capitalization825.75K
ALGS vs SQZB Comparison Chart in %
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. SQZB commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ALGS: $9.79 vs. SQZB: $0.03)
Brand notoriety: ALGS and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 81% vs. SQZB: 25%
Market capitalization -- ALGS: $68.05M vs. SQZB: $825.75K
ALGS [@Biotechnology] is valued at $68.05M. SQZB’s [@Biotechnology] market capitalization is $825.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, ALGS is a better buy in the long-term than SQZB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while SQZB’s TA Score has 3 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • SQZB’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than SQZB.

Price Growth

ALGS (@Biotechnology) experienced а +1.24% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

SQZB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGS($68.1M) has a higher market cap than SQZB($826K). SQZB YTD gains are higher at: -6.667 vs. ALGS (-75.427).
ALGSSQZBALGS / SQZB
Capitalization68.1M826K8,245%
EBITDA-75.81MN/A-
Gain YTD-75.427-6.6671,131%
P/E RatioN/AN/A-
Revenue3.17MN/A-
Total Cash123MN/A-
Total Debt6.88MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALGSSQZB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEKAY4.41N/A
N/A
NV Bekaert SA
FSDK63.00N/A
N/A
First Citizens National Bank of Upper Sandusky (The) (OH)
LOQPF5.96N/A
N/A
Accesso Technology Group Plc
OROVF16.80N/A
N/A
Orient Overseas International Ltd.
BAUFF0.17-0.01
-5.32%
Blue Star Gold Corp.

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with DYN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+4.59%
DYN - ALGS
40%
Loosely correlated
+4.53%
DSGN - ALGS
39%
Loosely correlated
+7.53%
XNCR - ALGS
39%
Loosely correlated
+12.00%
BEAM - ALGS
38%
Loosely correlated
-0.52%
CRNX - ALGS
38%
Loosely correlated
+27.92%
More

SQZB and

Correlation & Price change

A.I.dvisor tells us that SQZB and ATHA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SQZB and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
ATHA - SQZB
26%
Poorly correlated
+1.31%
OLMA - SQZB
13%
Poorly correlated
+16.12%
BRTX - SQZB
9%
Poorly correlated
-1.38%
ENTBF - SQZB
5%
Poorly correlated
-9.76%
ALGS - SQZB
2%
Poorly correlated
+4.59%
More